Pds biotech provides business update and reports first quarter 2023 financial results

Updated data from versatile-002 phase 2 trial to be presented at asco 2023 company to host conference call and webcast today, may 15, 2023, at 8:00 am et florham park, n.j., may 15, 2023 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb), a clinical-stage company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, will discuss its financial results for the quarter ended march 31, 2023, and provide a business update on its conference call today.
PDSB Ratings Summary
PDSB Quant Ranking